COMPANY INSIGHT

Sponsored by Capsugel

Lonza Pharma & Biotech – Capsule Delivery Solutions

Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is the leader in capsule-based solutions and services, proudly offering Capsugel® products. With the largest production and supply chain footprint in the industry, Capsule Delivery Solutions provides the highest quality and deepest regulatory expertise to its 2,000 pharmaceutical customers, globally

For more than 100 years, biopharmaceutical companies have relied on the quality, consistency and functional innovations Capsugel® has delivered; today we produces more than 200 billion capsules in over 100 countries.

Building on our history of innovation in polymer science and capsule engineering, Capsule Delivery Solutions continues to launch ground-breaking capsule designs and equipment technologies that are improving drug development and delivery. Whether you’re looking to formulate new products or enhance an existing line, we have the right capsule to help you bring improved products to market faster. With a diverse portfolio including HPMC, Dry Powder Inhalation capsules or specialized clinical capsules, we are a global leader in capsule development and manufacturing, bringing unmatched products and technical support to our worldwide customer base.

Capsule Delivery Solutions Quality  

From the purchase of key raw materials to the manufacturing, packaging and delivering of finished products, Capsule Delivery Solutions works to ensure the safety and quality of capsules we supply to pharmaceutical customers around the world.

As key elements of our quality commitment, Capsugel is investing in Regulatory Compliance Monitoring Programs that anticipates and proactively responds to the continuously evolving global food-safety standards and maintains a robust Quality System, from sourcing of our ingredients to the distribution of our products, that is compliant with all applicable standards.

Capsule Delivery Solutions offers  

High quality empty capsules:

  • Immediate release: Coni-Snap® Gelatin, Vcaps® Plus, Plantcaps®
  • Targeted & Modified release: Vcaps® Enteric, DUOCAP®
  • Dry Powder Inhalation capsules: Gelatin: Coni-Snap® Gelatin and Coni-Snap® Gelatin-PEG, HPMC: Vcaps® and Vcaps® Plus
  • Preclinical and clinical development capsules: PCcaps®, DBcaps®
  • Patient Centric capsules: Coni-Snap® Sprinkle
  • Life Cycle Management solutions: Press-Fit®, XPress-Fit®

Innovative and tailored services:

Go to article: Home | The power of patientsGo to article: Scandinavian Health Company InsightGo to article: Scandinavian Health Ltd.Go to article: In this issueGo to article: NSFGo to article: ContentsGo to article: CapsugelGo to article: Capsugel Company Insight Go to article: Christensella: the key to unlocking gut microbiome-based drug discovery?Go to article: Molnar Company InsightGo to article: Molnar-InstituteGo to article: A costly oversight: the ongoing impact of the valsartan recallGo to article: Novo Nordisk Company InsightGo to article: Novo NordiskGo to article: Where is the UK’s supply of Migraleve?Go to article: Dupont PharmaceuticalsGo to article: Discussing drug policy reform with psychedelics campaigner Amanda FeildingGo to article: LB Bohle Company Insight Go to article: LB BohleGo to article: Charting the life and times of the EMA as it leaves LondonGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: CBD: the myth, the magic and the real deal drugsGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: In the age of AMR, does a nationalised drug company make sense? The case for and againstGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: How do cancer cells communicate and can it help us catch them?Go to article: HOF SonderanlagenbauGo to article: HOF Sonderanlagenbau Company Insight Go to article: Buyers’ clubs: the first step toward universal UK access to Orkambi?Go to article: SterigenicsGo to article: Owen MumfordGo to article: Are we nearing the end of animal testing in pharma?Go to article: Zenatek Go to article: Barc Lab Go to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Abiogen PharmaGo to article: MimotopesGo to article: Next issue